A. Fritzberg

发表

Enhanced in vitro tumor cell retention and internalization of antibody derivatized with synthetic peptides.

D. Anderson, R. Manger, J. Morgan, 1993, Bioconjugate chemistry.

Comparison of iodine-131 OIH and technetium-99m MAG3 renal imaging in volunteers.

P. Christian, D. Eshima, A. Taylor, 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

I86Re Radioimmunotherapy of Small Cell Lung Carcinoma in Nude Mice

L. L. Kunz, P. Beaumier, P. Abrams, 2006 .

Radioimmunotherapy of Cancer

P. Abrams, A. Fritzberg, 2000 .

Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer.

D. Wilbur, M. Hylarides, P. Abrams, 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Approaches to improved antibody- and peptide-mediated targeting for imaging and therapy of cancer

P. Beaumier, J. Reno, A. Fritzberg, 1994 .

Successful imaging of malignant melanoma with technetium-99m-labeled monoclonal antibodies.

J. Eary, R. Schroff, Clive S. Woodhouse, 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

99mTc renal tubular function agents: current status.

D. Eshima, A. Taylor, A. Fritzberg, 1990, Seminars in nuclear medicine.

99mTc-glutathione: role of reducing agent on renal retention.

D. Lyster, D. Dolphin, A. Fritzberg, 1978, International journal of nuclear medicine and biology.

99mTc-ethylthiomethylphosphonate: a new renal scanning agent

D. Lyster, D. Dolphin, A. Fritzberg, 1977 .

Evaluation of formamidine sulfinic acid and other reducing agents for use in the preparation of Tc-99m labeled radiopharmaceuticals.

D. Lyster, D. Dolphin, A. Fritzberg, 1977, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Chemical and biological studies of Tc-99m N,N'-bis(mercaptoacetamido)-ethylenediamine: a potential replacement for I-131 iodohippurate.

C. Kuni, W. Klingensmith, A. Fritzberg, 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Approaches to Radiolabeling of Antibodies for Diagnosis and Therapy of Cancer

R. Berninger, D. Wester, A. Fritzberg, 1988, Pharmaceutical Research.

Development and biologic evaluation of a kit for preformed chelate technetium-99m radiolabeling of an antibody Fab fragment using a diamide dimercaptide chelating agent.

J. Fitzner, P. Beaumier, T. Rao, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Optimal antibody-radionuclide combinations for clinical radioimmunotherapy: a predictive model based on mouse pharmacokinetics.

E. Yorke, B. Wessels, P. Beaumier, 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy.

M. Welch, Mu Wang, C. Anderson, 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

High-dose 166Ho-DOTMP in myeloablative treatment of multiple myeloma: pharmacokinetics, biodistribution, and absorbed dose estimation.

J. Eary, J. Rajendran, W. Bensinger, 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Melanoma Therapy via Peptide-Targeted α-Radiation

T. Quinn, D. Fisher, T. Hoffman, 2005, Clinical Cancer Research.

186Re-labeled antibodies to p185HER2 as HER2-targeted radioimmunopharmaceutical agents: comparison of physical and biological characteristics with 125I and 131I-labeled counterparts.

C. Kotts, H. Shepard, D. Slamon, 1996, Cancer biotherapy & radiopharmaceuticals.

Biodistribution of p-iodobenzoyl (PIP) labeled antibodies in a murine lymphoma model.

I. Bernstein, D. Wilbur, C. Badger, 1990, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Targeted proteins for diagnostic imaging: does chemistry make a difference?

P. Beaumier, A. Fritzberg, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Tumor cell retention of antibody Fab fragments is enhanced by an attached HIV TAT protein-derived peptide.

D. Anderson, R. Manger, E. Nichols, 1993, Biochemical and biophysical research communications.

Technetium (V) and rhenium (V) complexes of 2,3-bis(mercaptoacetamido)propanoate. Chelate ring stereochemistry and influence on chemical and biological properties

A. Camerman, T. Rao, A. Fritzberg, 1990 .

Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agent.

D. Wilbur, P. Beaumier, T. Rao, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Tissue distribution properties of technetium-99m-diamide-dimercaptide complexes and potential use as renal radiopharmaceuticals.

D. Eshima, D. Johnson, A. Fritzberg, 1986, Journal of medicinal chemistry.

Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator.

P. Beaumier, D. Axworthy, F. Su, 2005, Nuclear medicine and biology.

Pretargeted α Emitting Radioimmunotherapy Using 213Bi 1,4,7,10-Tetraazacyclododecane-N,N′,N″,N‴-Tetraacetic Acid-Biotin

William C Eckelman, Ira Pastan, Chang H Paik, 2004, Clinical Cancer Research.

Melanoma therapy via peptide-targeted {alpha}-radiation.

T. Quinn, D. Fisher, T. Hoffman, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

Studies on the incorporation of (2S, 3R)-(4,4,4-2H3)valine and (2S,3S)-4,4,4-2H3)Valine into beta-lactam antibiotics.

C. Sih, H. Schnoes, F. Huang, 1974, Journal of the American Chemical Society.

Advances in 99mTc-Labeling of Antibodies

A. Fritzberg, 1987, Nuklearmedizin.

Components for the Design of a Radio-HPLC System

A. Nunn, A. Fritzberg, 1986 .

99mTc-interleukin-2 scintigraphy in normal subjects and in patients with autoimmune thyroid diseases: a feasibility study

A. Grossman, S. Mather, A. Signore, 2008, European Journal of Nuclear Medicine and Molecular Imaging.

The development of technetium-99m-labelled interleukin-2: a new radiopharmaceutical for the in vivo detection of mononuclear cell infiltrates in immune-mediated diseases.

S. Mather, A. Signore, M. Chianelli, 1997, Nuclear medicine and biology.

Rhenium-186-labeled chimeric antibody NR-LU-13: pharmacokinetics, biodistribution and immunogenicity relative to murine analog NR-LU-10.

P. Beaumier, P. Weiden, M. Bjorn, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Technetium(V) and Rhenium(V) Complexes of 2,3-Bis(mercaptoacetamido)propanoate. Chelate Ring Stereochemistry and Influence on Chemical and Biological Properties.

A. Camerman, T. Rao, A. Fritzberg, 1990 .

Biodistribution and renal excretion of 99mTc-N,N'-bis-(Mercaptoacetamido) ethylenediamine. Effect of renal tubular transport inhibitors.

C. Kuni, W. Klingensmith, A. Fritzberg, 1982, International journal of nuclear medicine and biology.

Kinetics and mechanism of reactions of S-protected dithiol monoaminemonoamide (MAMA) ligands with technetium: Characterization of a technetium—thiolate—thioether—MAMA complex, a kinetic intermediate of the reaction

T. Rao, A. Fritzberg, S. Kasina, 1992 .

Synthesis and characterization of monooxorhenium(V) complexes of mercaptoacetylglycylglycylglycine. Crystal structure of tetrabutylammonium oxo(mercaptoacetylglycylglycylglycine)rhenate(V)

A. Camerman, T. Rao, A. Fritzberg, 1991 .

Synthesis and characterization of diamide dithiol complexes of technetium(V) and rhenium(V). Assignment of the stereochemistry of the chelate epimers by NMR spectroscopy

D. Brixner, J. Vanderheyden, T. Rao, 1991 .

Biodistribution, pharmacokinetic, and imaging studies with 186Re-labeled NR-LU-10 whole antibody in LS174T colonic tumor-bearing mice.

K. Foon, J. Vanderheyden, M. Goldrosen, 1990, Cancer research.

PRECLINICAL EVALUATION OF AN ANTI-TUMOR MONCLONAL ANTIBODY/ STREPTAVIDIN CONJUGATE FOR PRETARGETED 90Y RADIOIMMUNOTHERAPY IN A MOUSE XENOGRAFT MODEL

P. Beaumier, M. Hylarides, D. Axworthy, 1994 .

Synthesis of a new class of Tc chelating agents: N2S2 monoaminemonoamide (mama) ligands

T. Rao, D. S. Jones, A. Fritzberg, 1991 .

Antibody pretargeted radiotherapy: a new approach and a second chance.

A. Fritzberg, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Preparation of 213bi-dota-biotin in high specific activity for pretargeted alpha radiotherapy of cancer

M. Hylarides, D. Axworthy, A. Fritzberg, 2001 .

Radio-HPLC: Application to Organics and Metal Chelate Chemistry

A. Nunn, A. Fritzberg, 1986 .

Convenient synthesis of vicinal diamines

D. S. Jones, A. Fritzberg, S. Kasina, 1989 .

Synthesis and iodination of methyl 4-tri-n-butylstannylbenzoate, p-(methoxycarbonyl)phenylmercuric chloride and p-(methoxycarbonyl)phenylboronic acid

D. Wilbur, M. Hylarides, A. Fritzberg, 1989 .

Stereochemistry of opening of cyclopropanols. trans-2,3-Di-tert-butylcyclopropanone hemiketals

A. Fritzberg, P. Wharton, 1972 .

Structures, stereochemistry and liquid chromatography properties of technetium and rhenium diamide dimercaptide complexes

A. Camerman, J. Vanderheyden, T. Rao, 1989 .

HPLC analysis of Tc-99m iminodiacetate hepatobiliary agents and a question of multiple peaks: concise communication.

A. Fritzberg, D. Lewis, 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity.

P. Beaumier, M. Hylarides, D. Axworthy, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Metallic Radionuclides for Radioimmunotherapy

C. Meares, A. Fritzberg, 2000 .

99mTc-bioquin-7CA, a potential new hepatobiliary scanning agent.

D. Lyster, D. Dolphin, A. Fritzberg, 1976, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

99mTc-Bloquln-7CA, a Potential New Hepatobillary Scan nlng Agent

D. Lyster, D. Dolphin, A. Fritzberg, 1976 .

Clinical evaluation of Tc-99m N,N'-bis(mercaptoacetyl)-2,3-diaminopropanoate as a replacement for I-131 hippurate: concise communication.

V. Spitzer, C. Kuni, M. Williamson, 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Animal Models in the Study of Hepatobiliary Radiotracers

D. Bloedow, A. Fritzberg, 1983 .

Comparison of [99mTc]parabutyl-IDA and [99mTc]diethyl-IDA for imaging the hepatobiliary system in patients with hyperbilirubinemia.

C. Kuni, J. Lilly, W. Klingensmith, 1982, International journal of nuclear medicine and biology.

Diagnosis of biliary atresia with radionuclide hepatobiliary imaging.

C. Kuni, J. Lilly, W. Klingensmith, 1983, Radiology.

Relative Role of Tc-99m-Diethyl-IDA and Tc-99m-Sulfur Colloid in the Evaluation of Liver Function

G. Zerbe, W. Klingensmith, L. Koep, 1980, Clinical nuclear medicine.

Comparison of Tc-99m diethyl-iminodiacetic acid and I-131 rose bengal for hepatobiliary studies in liver-transplant patients: Concise communication.

W. Klingensmith, L. Koep, A. Fritzberg, 1979, Journal of Nuclear Medicine.

A clinical comparison of 99mTc-diethyl-iminodiacetic acid, 99mTc-pyridoxylideneglutamate, and 131I-rose bengal in liver transplant patients.

P. Ronai, W. Klingensmith, L. Koep, 1979, Radiology.

Bile leak into a hepatic abscess in a liver transplant: demonstration with 99mTc-diethyl-iminodiacetic acid.

W. Klingensmith, L. Koep, A. Fritzberg, 1978, AJR. American journal of roentgenology.

Comparative study of 99mTc labeled hepatobiliary agents based on naphthalene and similar ring systems.

D. Bloedow, W. Klingensmith, A. Fritzberg, 1982, International journal of nuclear medicine and biology.

Extraction efficiency and biliary excretion of hepatobiliary imaging agents in the rat perfused liver

A. Fritzberg, Juerg Reichen, 1985, The Journal of pharmacy and pharmacology.

Normal appearance and reproducibility of liver-spleen studies with Tc-99m sulfur colloid and Tc-99m microalbumin colloid.

V. Spitzer, C. Kuni, W. Klingensmith, 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Clinical comparison of 99mTc-diethyl-IDA and 99mTc-PIPIDA for evaluation of the hepatobiliary system.

V. Spitzer, W. Klingensmith, L. Koep, 1980, Radiology.

Quest for the perfect hepatobiliary radiopharmaceutical.

W. Klingensmith, A. Fritzberg, 1982, Journal of Nuclear Medicine.

Animal evaluation of technetium-99m triamide mercaptide complexes as potential renal imaging agents.

L. Hansen, D. Eshima, A. Taylor, 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement.

D. Eshima, D. Johnson, D L Johnson, 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

The investigation of radiopharmaceutical components by fast atom bombardment mass spectrometry: the identification of Tc-HIDA and the epimers of Tc-CO2DADS.

C. Costello, D. Johnson, A. Davison, 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Clinical comparison of diisopropyl-IDA Tc 99m and diethyl-IDA Tc 99m for evaluation of the hepatobiliary system.

V. Spitzer, C. Kuni, W. Klingensmith, 1981, Radiology.

Comparison of 99mTc-N-pyridoxyl-5-methyltryptophan and 99mTc-N-(3-bromo-2,4,6-trimethylacetanilide)-iminodiace tate as hepatobiliary radiopharmaceuticals in rats.

D. Eshima, D. Johnson, D. Bloedow, 1984, Journal of pharmaceutical sciences.

Clinical Comparison of Technetium-99m-N,N'-bis(Mercaptoacetyl)-2,3-Diaminopropanoate with Technetium-99m DTPA for Renal Imaging

V. Spitzer, C. Kuni, W. Klingensmith, 1985, Clinical nuclear medicine.

Effect of hydration and dehydration on technetium-99m CO2 DADS renal studies in normal volunteers.

G. Hanna, W. Klingensmith, A. Fritzberg, 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Synthesis and biological evaluation of Tc-99m N,N'-bis(mercaptoacetyl)-2,3-diaminopropanoate: a potential replacement for [131I]o-iodohippurate.

C. Kuni, W. Klingensmith, A. Fritzberg, 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Clinical comparison of Tc-99m N,N'-bis(mercaptoacetamido)ethylenediamine and [131I]ortho-iodohippurate for evaluation of renal tubular function: concise communication.

V. Spitzer, C. Kuni, W. Klingensmith, 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Radiolabeled antibodies for the management of metastatic cancer

H. Breitz, A. Fritzberg, 2003 .

Radiolabeled Monoclonal Antibodies for Localization and Treatment of Metastatic Cancer

P. Weiden, P. Abrams, H. Breitz, 1998 .

Measurement of adenosine triphosphate and 2,3-diphosphoglycerate in stored blood with 31P nuclear magnetic resonance spectroscopy.

E. McCabe, D. Johnson, B. Hawkins, 1986, Biochemical medicine and metabolic biology.

Fritzberg Advances in " mTc-Labeling

A. Fritzberg, Advances in Tc-Labeling, 2017 .

Radioimaging of Melanoma with 99Tcm-labeled Monoclonal Antibodies

J. Eary, W. Nelp, S. L. Johnson, 1990 .

Radiohalogenated small molecules for protein labeling

D. Wilbur, A. Fritzberg, 1993 .

Radiohalogenated for proteins

D. Wilbur, D. S. Jones, A. Fritzberg, 1990 .

Complementary role of Tc-99m-diethyl-IDA and ultrasound in large and small duct biliary tract obstruction.

C. Kuni, M. L. Johnson, W. Klingensmith, 1981, Radiology.

Communication of Intrahepatic Cavities with Bile Ducts: Demonstration with Tc-99m-Diethyl-IDA Imaging

C. Kuni, W. Klingensmith, L. Koep, 1980, Clinical nuclear medicine.

Cholescintigraphy in extrahepatic biliary obstruction.

C. Kuni, W. Klingensmith, A. Fritzberg, 1982, AJR. American journal of roentgenology.

CHEMICAL AND BIOLOGICAL STUDIES OF TC-99M ETHYLENEDIAMINE: A POTENTIAL REPLACEMENT FOR I-131-IODOHIPPURATE

C. Kuni, W. Klingensmith, A. Fritzberg, 1981 .

Biorecognition of antibodies in vivo: potential in drug targeting

A. Fritzberg, 1996, Journal of molecular recognition : JMR.

186Re radioimmunotherapy of small cell lung carcinoma xenografts in nude mice.

L. Kunz, L. L. Kunz, J. Vanderheyden, 1991, Cancer research.

99mTc Labelling of Interleukin-2 for in Vivo Targeting of Activated T-Lymphocytes

G. Ronga, S. Mather, A. Signore, 1994 .

Simplified preformed chelate protein radiolabeling with technetium-99m mercaptoacetamidoadipoylglycylglycine (N3S-adipate).

J. Fitzner, P. Beaumier, T. Rao, 1998, Bioconjugate chemistry.

Stereochemical studies in the development of technetium radiopharmaceuticals. 1. Fluxional racemization of technetium and rhenium penicillamine complexes

D. Eshima, D. Johnson, B. Hawkins, 1984 .

Iodophenylsulfonamide fatty acid analogs as potential myocardial imaging agents.

D. Eshima, A. Fritzberg, 1982, The International journal of applied radiation and isotopes.

Comparison of a new Tc-99m renal function agent, Tc-99m mercaptoacetyltriglycine, with I-131 OIH

D. Eshima, D. Johnson, A. Fritzberg, 1985 .